Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082903 | SCV000656080 | likely benign | Neuropathy, hereditary motor and sensory, type 6B | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000556314 | SCV001154451 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | SLC25A46: BP4, BS2 |
Gene |
RCV000556314 | SCV001803381 | likely benign | not provided | 2021-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367954 | SCV002660616 | likely benign | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003900235 | SCV004725742 | likely benign | SLC25A46-related disorder | 2020-02-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV000556314 | SCV005221467 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001701050 | SCV001918995 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000556314 | SCV001970800 | likely benign | not provided | no assertion criteria provided | clinical testing |